文献速递腹部MR

肝细胞癌微血管侵犯MRI特征显示中肝胆特异性对比剂表现的对比分析

Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2024-06-02

回顾性纳入111个肝细胞癌病灶,分别使用Gd-EOB-DTPA或Gd-BOPTA行多期动态增强MRI,由两名腹部放射科医师独立评估四项MVI征象。Gd-EOB-DTPA在肝胆期显示全部四项征象均有显著差异,Gd-BOPTA仅两项有显著差异;延迟期包膜不完整诊断MVI的AUC最高,联合四项特征时Gd-BOPTA的AUC(0.9312)优于Gd-EOB-DTPA(0.8712)。

要点

  • 延迟期包膜不完整与病理相关性最高,Gd-BOPTA的AUC为0.843,Gd-EOB-DTPA为0.761。
  • 联合四项MRI特征时Gd-BOPTA的AUC为0.9312,优于Gd-EOB-DTPA的0.8712。
  • 肝胆期Gd-EOB-DTPA显示全部四项MVI征象均有显著差异,Gd-BOPTA仅两项有显著差异。

核心结论

  • 肝胆特异性对比剂动态增强MRI的四项特征在评估肝细胞癌MVI时与组织病理学结果有良好相关性,具有一定临床意义。

研究设计与样本

  • 回顾性研究,纳入111个肝细胞癌病灶,分别使用Gd-EOB-DTPA或Gd-BOPTA行多期动态增强MRI,包括动脉期、门静脉期、移行期、延迟期和肝胆期,由两名腹部放射科医师独立评估,第三名资深腹部放射科医师复核,以病理为参考标准。

关键影像表现/征象

  • 评估的四项MVI征象为瘤周强化、包膜不完整、肿瘤边缘不光滑和瘤周低信号。
  • 肝胆期Gd-BOPTA显示两项征象有显著差异(P<0.05:0.000,0.000)。
  • 肝胆期Gd-EOB-DTPA显示全部四项征象均有显著差异(P<0.05:0.005,0.006,0.000,0.002)。

诊断标准与关键数值

  • 延迟期包膜不完整评估MVI与病理相关性最高,Gd-BOPTA的AUC为0.843,Gd-EOB-DTPA的AUC为0.761。
  • 联合四项MRI特征时Gd-BOPTA与病理显著相关,AUC为0.9312;Gd-EOB-DTPA亦显著相关,AUC为0.8712;Gd-BOPTA优于Gd-EOB-DTPA。

临床应用与阅片要点

  • 阅片评估肝细胞癌MVI时,可关注瘤周强化、包膜不完整、肿瘤边缘不光滑和瘤周低信号四项征象。
  • 延迟期包膜不完整与病理相关性最高,联合四项特征可提高与病理的相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the ability to depict MRI features of hepatobiliary agents in microvascular infiltration (MVI) of hepatocellular carcinoma (HCC) during different stages of dynamic enhancement MRI.

MATERIALS AND METHODS: A retrospective study included 111 HCC lesions scanned with either Gd-EOB-DTPA or Gd-BOPTA. All cases underwent multiphase dynamic contrast-enhanced scanning before surgery, including arterial phase (AP), portal venous phase (PVP), transitional phase (TP), delayed phase (DP), and hepatobiliary phase (HBP). Two abdominal radiologists independently evaluated MRI features of MVI in HCC, such as peritumoral hyperenhancement, incomplete capsule, non-smooth tumor margins, and peritumoral hypointensity. Finally, the results were reviewed by the third senior abdominal radiologist. Chi-square (χ2) Inspection for comparison between groups. P < 0.05 is considered statistically significant. Receiver operating characteristic (ROC) curve was used to evaluate correlation with pathology, and the area under the curve (AUC) and 95% confidence interval (95% CI) were calculated.

RESULTS: Among the four MVI evaluation signs, Gd-BOPTA showed significant differences in displaying two signs in the HBP (P < 0.05:0.000, 0.000), while Gd-EOB-DTPA exhibited significant differences in displaying all four signs (P < 0.05:0.005, 0.006, 0.000, 0.002). The results of the evaluations of the two contrast agents in the DP phase with incomplete capsulation showed the highest correlation with pathology (AUC: 0.843, 0.761). By combining the four MRI features, Gd-BOPTA and Gd-EOB-DTPA have correlated significantly with pathology, and Gd-BOPTA is better (AUC: 0.9312vs0.8712).

CONCLUSION: The four features of hepatobiliary agent dynamic enhancement MRI demonstrate a good correlation with histopathological findings in the evaluation of MVI in HCC, and have certain clinical significance.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yao WW, Zhang HW, Ma YP, et al. Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma. Abdom Radiol (NY). 2024. PMID: 38824474. doi:10.1007/s00261-024-04311-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。